Email
Print
Digital Breast Tomosynthesis Market - Forecast(2024 - 2030)
Digital Breast Tomosynthesis Market Overview
Digital Breast Tomosynthesis Market size is estimated at $2.8 billion in 2021, projected to grow at a CAGR of 13.2% during the forecast period 2022-2027. Digital Breast Tomosynthesis (DBT) is a kind of breast imaging, or mammography, which converts x-ray images of the breast into a three-dimensional image set using low-dose x-ray equipment, electronics, and a computer. It's used to provide high-resolution limited-angle tomography at radiation doses comparable to protection radiography and for detecting and diagnosing cancer at an early stage. Projectional radiography or conventional radiography produces two-dimensional images by x-ray radiations. DBT is also known as 3d mammography. According to German research published in October 2021 in European Radiology, when compared to conventional mammography alone, combining digital breast tomosynthesis (DBT) with synthesized 2D mammography results in greater cancer detection rates with fewer recalls. Synthetic mammography uses DBT data to recreate 2D images, requiring no additional radiation. Image quality is key to early detection. Hologic's, a medical technology company primarily focused on women’s health, direct conversion detector is used in the Selenia Dimensions Hologic, eliminating the need to convert x-rays to light. As a result, the digital images are exceedingly sharp and have a high Detective Quantum Efficiency (DQE), allowing for low-dose tomosynthesis imaging.
Increasing prevalence of breast cancer, technological advancements for the detection and diagnosis of cancer and growing awareness about the benefits of tomosynthesis are some of the factors driving the Digital Breast Tomosynthesis industry forward in the projected period of 2022-2027.
Report Coverage
The report: “Digital Breast Tomosynthesis Market Forecast (2022-2027)", by Industry ARC covers an in-depth analysis of the following segments of the Digital Breast Tomosynthesis Market.
By Product Type- 2D/3D Combination Mammography Systems and Standalone 3D Mammography Systems
By End-User- Hospitals, Diagnostic Centers, and Others
By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (the Middle East, and Africa).
Key Takeaways
- Geographically, North America held a dominant market share in the year 2021 owing to the increasing prevalence of breast cancer cases and developed healthcare infrastructure. Additionally, Asia-Pacific is expected to offer lucrative growth opportunities to the marketers owing to rising healthcare expenditure and increasing awareness about Digital Breast Tomosynthesis. The robust growth in the end-use industries such as hospitals and diagnostic centers are some of the factors driving the market growth.
- The increasing prevalence of breast cancer globally and technological advancements is predicted to augment the market growth during the forecast period of 2022-2027. Hugh operation and installation cost accompanied with the risk of harmful radiations continues to pose threat to the market growth.
- A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Digital Breast Tomosynthesis Market Report.
Digital Breast Tomosynthesis Market: Market Share (%) by Region, 2021
For more details on this report - Request for Sample
Digital Breast Tomosynthesis Segment Analysis- By Product Type
The Digital Breast Tomosynthesis based on product type can be further segmented into 2D/3D Combination Mammography Systems and Standalone 3D Mammography Systems. 2D/3D Combination Mammography Systems held a dominant market share in the year 2021 and is estimated to be the fastest-growing, with a CAGR of 7.9% over the forecast period of 2022-2027. 2D/3D Mammography Systems require less follow-up imaging, detect more cancers than standard mammography alone, and improve breast cancer detection in dense breast tissues. According to a study published in June 2018 in RSNA’s Radiology Journal, 90 percent more breast cancers are detected when doctors combine 2D and 3D mammography. High detection rate, rising awareness among people about 2D/3D combination Mammography system, and increasing prevalence of breast cancer are the key factors driving the market growth. The Screening with Tomosynthesis study, conducted by researchers in Italy in 2016, discovered that the combined procedures detected a greater number of breast cancer cases than 2D mammograms alone. The cancer detection rate for 2D-3D mammography was 8.5 per 1000 screenings, compared to 6.3 per 1000 screens for 2D mammography alone. Technological developments in this segment are predicted to fuel the growth in the forecast period 2022-2027.
Digital Breast Tomosynthesis Segment Analysis- By End User
The Digital Breast Tomosynthesis based on end-user can be further segmented into Hospitals, Diagnostic Centers, and Others. Hospitals held a dominant market share in the year 2021 owing to increased healthcare infrastructure spending by countries, technological advancements in the hospital industry ad a rising number of breast cancer patients. According to the American Cancer Society, Breast cancer is the second leading cause of cancer death in women. It is about 30% or 1 in 3 of all new female cancers each year which drives the segment growth. The increased demand for Digital Breast Tomosynthesis Systems by doctors is another key factor driving the market growth as it allows them to spot abnormalities that might remain hidden while using conventional mammograms and helps them to detect other signs of breast cancer precisely.
However, the Diagnostic Centres segment is estimated to be the fastest-growing, with a CAGR of 6.2% over the forecast period of 2022-2027 owing to their increasing number globally on account of early wellness testing and diagnostics, awareness on preventive health, and increasing healthcare expenditures. According to the American Cancer Society, the 5-year relative survival rate for breast cancer when identified early and at the localized stage is 99 percent. Monthly breast self-exams, as well as clinical breast exams and mammography, are all part of early detection.
Digital Breast Tomosynthesis Segment Analysis- By Geography
The Digital Breast Tomosynthesis market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held a dominant market share of 39% in the year 2021 as compared to its other counterparts. It is owing to the trained healthcare professionals, highly developed healthcare infrastructure, higher affordability rate, and increasing incidence of breast cancer disease. Breast cancer is the most frequent cancer among women in the United States. Over the course of their lifetime, one in every eight American women (about 13 percent) will get invasive breast cancer.
However, Asia-Pacific is estimated to be the fastest-growing, with a CAGR of 9.4% over the forecast period of 2022-2027 owing to increasing government initiatives to promote awareness about breast cancer treatment, investments by companies in developing countries, rising disposable income, and growing population in countries like China and India. For instance, free breast cancer screening is provided to 1 lakh women in Goa as part of the 'Swasth Mahila, Swasth Goa' initiative, which was launched by an international cricketing icon in collaboration with the SBI foundation and the state government, ensuring that 50% of the state's age-eligible female population is screened. BreastScreen Australia is a joint project of the Australian and state and territory governments that aims to minimize breast cancer-related illness and death by early detection. Every two years, women over the age of 40 are given a free mammogram.
Digital Breast Tomosynthesis Market Drivers
Increasing Prevalence of Breast Cancer Is Augmenting the Market Growth
The rising prevalence of breast cancer globally is one of the key drivers of market growth. According to the World Health Organization, 2.3 million women were diagnosed with breast cancer in 2020, with 685 000 fatalities worldwide. Breast cancer had been diagnosed in 7.8 million women in the previous five years as of the end of 2020, making it the most common cancer in the world. Digital Breast Tomosynthesis is a technique that enables the three-dimensional reconstruction of breast tissue, which can then be viewed as consecutive sections across the breast. It increases breast cancer detection while lowering the false-positive or recall rate. Furthermore, it increases the detection of ductal carcinoma in situ, which are little abnormal tissue growths restricted to the milk ducts of the breast (DCIS). If these tumors are removed at an early stage, they rarely cause any harm to the patient, thereby, driving the Digital Breast Tomosynthesis Industry.
Increased awareness about breast cancer and the benefits of tomosynthesis has aided market growth.
The rise in public awareness regarding the advantages of Digital Breast Tomosynthesis, as well as the increase in healthcare expenditure by consumers, are propelling the market growth for Digital Breast Tomosynthesis forward. Many organizations are working towards spreading awareness about breast cancer drugs globally. For instance, in March 2020, World Health Organisation (WHO) hosted an advocacy event “Hearing the call of women with breast cancer” and presented their new initiative named Global Breast Cancer Initiative with the objective of reducing global breast cancer mortality by 2.5% per year until 2040. The Breast Cancer Foundation is always at the forefront for spreading awareness about breast cancer and the latest technological advancements in its treatments, empowerment, and support programs in Malaysia driving the market growth.
Digital Breast Tomosynthesis Market Challenges
High Cost and Excessive Exposure to Radiations Is Limiting The Market Development.
The high operation and installation cost of 2D/3D combination mammography systems is predicted to hinder the Digital Breast Tomosynthesis industry growth during the forecast period. 2D mammography systems cost roughly 30% less as compared to 2D/3D combination mammography systems. Excessive exposure to radiation always carries a small risk of cancer. Digital Breast tomosynthesis uses a slightly higher dose of radiation than 2D mammography. Sometimes 2D/3D combination mammography systems may show an abnormality that after other tests turn out to be benign or consistent with normal tissue. This is known as a false-positive result and it can cause anxiety if the patient decides to go for additional imaging and testing, for instance, a biopsy to further assess the area which costs time and money and even physical discomfort, thereby, limiting the market growth.
Digital Breast Tomosynthesis Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Digital Breast Tomosynthesis Market. The top 10 Digital Breast Tomosynthesis Market companies are-
- Hologic, Inc
- GE Healthcare
- Fujifilm Holdings Corporation
- Dexela Ltd.
- Planmed OY
- Siemens Healthineers
- General Medical Merate SpA (IMS GIOTTO SPA)
- Analogic Corporation
- Trivitron Healthcare
- Metaltronica Spa
Recent Developments
- In August 2021, FUJIFILM Medical Systems announced that its ASPIRE Cristalle mammography system with digital breast tomosynthesis (DBT) now offers ScreenPoint Medical’s new, FDA cleared Transpara powered by Fusion AI for 2D and 3D mammography in the United States. Transpara is an artificial intelligence (AI) technology aimed at assisting radiologists in improving reading accuracy, reducing reading time, and streamlining workflow.
- In December 2020, Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health, received FDA clearance and commercial availability for the Company’s Genius AI™ Detection technology. It's a new deep learning-based software that can assist radiologists to detect probable tumors in tomosynthesis images of the breast. The software provides crucial parameters during image acquisition to assist radiologists in categorizing and prioritizing cases based on their complexity and predicted read time in order to improve workflow and speed up patient care.
Relevant Titles
Metastatic
Breast Cancer Market
Report Code: HCR 0340
Breast
Cancer Screening Tests Market
Report Code: HCR 50158
For more Lifesciences and Healthcare related reports, please click here
Table 1: Digital Breast Tomosynthesis Market Overview 2023-2030
Table 2: Digital Breast Tomosynthesis Market Leader Analysis 2023-2030 (US$)
Table 3: Digital Breast Tomosynthesis Market Product Analysis 2023-2030 (US$)
Table 4: Digital Breast Tomosynthesis Market End User Analysis 2023-2030 (US$)
Table 5: Digital Breast Tomosynthesis Market Patent Analysis 2013-2023* (US$)
Table 6: Digital Breast Tomosynthesis Market Financial Analysis 2023-2030 (US$)
Table 7: Digital Breast Tomosynthesis Market Driver Analysis 2023-2030 (US$)
Table 8: Digital Breast Tomosynthesis Market Challenges Analysis 2023-2030 (US$)
Table 9: Digital Breast Tomosynthesis Market Constraint Analysis 2023-2030 (US$)
Table 10: Digital Breast Tomosynthesis Market Supplier Bargaining Power Analysis 2023-2030 (US$)
Table 11: Digital Breast Tomosynthesis Market Buyer Bargaining Power Analysis 2023-2030 (US$)
Table 12: Digital Breast Tomosynthesis Market Threat of Substitutes Analysis 2023-2030 (US$)
Table 13: Digital Breast Tomosynthesis Market Threat of New Entrants Analysis 2023-2030 (US$)
Table 14: Digital Breast Tomosynthesis Market Degree of Competition Analysis 2023-2030 (US$)
Table 15: Digital Breast Tomosynthesis Market Value Chain Analysis 2023-2030 (US$)
Table 16: Digital Breast Tomosynthesis Market Pricing Analysis 2023-2030 (US$)
Table 17: Digital Breast Tomosynthesis Market Opportunities Analysis 2023-2030 (US$)
Table 18: Digital Breast Tomosynthesis Market Product Life Cycle Analysis 2023-2030 (US$)
Table 19: Digital Breast Tomosynthesis Market Supplier Analysis 2023-2030 (US$)
Table 20: Digital Breast Tomosynthesis Market Distributor Analysis 2023-2030 (US$)
Table 21: Digital Breast Tomosynthesis Market Trend Analysis 2023-2030 (US$)
Table 22: Digital Breast Tomosynthesis Market Size 2023 (US$)
Table 23: Digital Breast Tomosynthesis Market Forecast Analysis 2023-2030 (US$)
Table 24: Digital Breast Tomosynthesis Market Sales Forecast Analysis 2023-2030 (Units)
Table 25: Digital Breast Tomosynthesis Market By Product, Revenue & Volume,By DBT Equipment, 2023-2030 ($)
Table 26: Digital Breast Tomosynthesis Market By Product, Revenue & Volume,By 3-D Upgradation, 2023-2030 ($)
Table 27: Digital Breast Tomosynthesis Market, Revenue & Volume,By End-User, 2023-2030 ($)
Table 28: Digital Breast Tomosynthesis Market By End-User, Revenue & Volume,By Hospitals, 2023-2030 ($)
Table 29: Digital Breast Tomosynthesis Market By End-User, Revenue & Volume,By Diagnostic Centres, 2023-2030 ($)
Table 30: North America Digital Breast Tomosynthesis Market, Revenue & Volume,By Product, 2023-2030 ($)
Table 31: North America Digital Breast Tomosynthesis Market, Revenue & Volume,By End-User, 2023-2030 ($)
Table 32: South america Digital Breast Tomosynthesis Market, Revenue & Volume,By Product, 2023-2030 ($)
Table 33: South america Digital Breast Tomosynthesis Market, Revenue & Volume,By End-User, 2023-2030 ($)
Table 34: Europe Digital Breast Tomosynthesis Market, Revenue & Volume,By Product, 2023-2030 ($)
Table 35: Europe Digital Breast Tomosynthesis Market, Revenue & Volume,By End-User, 2023-2030 ($)
Table 36: APAC Digital Breast Tomosynthesis Market, Revenue & Volume,By Product, 2023-2030 ($)
Table 37: APAC Digital Breast Tomosynthesis Market, Revenue & Volume,By End-User, 2023-2030 ($)
Table 38: Middle East & Africa Digital Breast Tomosynthesis Market, Revenue & Volume,By Product, 2023-2030 ($)
Table 39: Middle East & Africa Digital Breast Tomosynthesis Market, Revenue & Volume,By End-User, 2023-2030 ($)
Table 40: Russia Digital Breast Tomosynthesis Market, Revenue & Volume,By Product, 2023-2030 ($)
Table 41: Russia Digital Breast Tomosynthesis Market, Revenue & Volume,By End-User, 2023-2030 ($)
Table 42: Israel Digital Breast Tomosynthesis Market, Revenue & Volume,By Product, 2023-2030 ($)
Table 43: Israel Digital Breast Tomosynthesis Market, Revenue & Volume,By End-User, 2023-2030 ($)
Table 44: Top Companies 2023 (US$)Digital Breast Tomosynthesis Market, Revenue & Volume
Table 45: Product Launch 2023-2030Digital Breast Tomosynthesis Market, Revenue & Volume
Table 46: Mergers & Acquistions 2023-2030Digital Breast Tomosynthesis Market, Revenue & Volume
List of Figures
Figure 1: Overview of Digital Breast Tomosynthesis Market 2023-2030
Figure 2: Market Share Analysis for Digital Breast Tomosynthesis Market 2023 (US$)
Figure 3: Product Comparison in Digital Breast Tomosynthesis Market 2023-2030 (US$)
Figure 4: End User Profile for Digital Breast Tomosynthesis Market 2023-2030 (US$)
Figure 5: Patent Application and Grant in Digital Breast Tomosynthesis Market 2013-2023* (US$)
Figure 6: Top 5 Companies Financial Analysis in Digital Breast Tomosynthesis Market 2023-2030 (US$)
Figure 7: Market Entry Strategy in Digital Breast Tomosynthesis Market 2023-2030
Figure 8: Ecosystem Analysis in Digital Breast Tomosynthesis Market 2023
Figure 9: Average Selling Price in Digital Breast Tomosynthesis Market 2023-2030
Figure 10: Top Opportunites in Digital Breast Tomosynthesis Market 2023-2030
Figure 11: Market Life Cycle Analysis in Digital Breast Tomosynthesis Market
Figure 12: GlobalBy ProductDigital Breast Tomosynthesis Market Revenue, 2023-2030 ($)
Figure 13: GlobalBy End-UserDigital Breast Tomosynthesis Market Revenue, 2023-2030 ($)
Figure 14: Global Digital Breast Tomosynthesis Market - By Geography
Figure 15: Global Digital Breast Tomosynthesis Market Value & Volume, By Geography, 2023-2030 ($)
Figure 16: Global Digital Breast Tomosynthesis Market CAGR, By Geography, 2023-2030 (%)
Figure 17: North America Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 18: US Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 19: US GDP and Population, 2023-2030 ($)
Figure 20: US GDP – Composition of 2023, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2023-2030 ($)
Figure 22: Canada Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 23: Canada GDP and Population, 2023-2030 ($)
Figure 24: Canada GDP – Composition of 2023, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2023-2030 ($)
Figure 26: Mexico Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 27: Mexico GDP and Population, 2023-2030 ($)
Figure 28: Mexico GDP – Composition of 2023, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2023-2030 ($)
Figure 30: South America Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 31: Brazil Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 32: Brazil GDP and Population, 2023-2030 ($)
Figure 33: Brazil GDP – Composition of 2023, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2023-2030 ($)
Figure 35: Venezuela Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 36: Venezuela GDP and Population, 2023-2030 ($)
Figure 37: Venezuela GDP – Composition of 2023, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2023-2030 ($)
Figure 39: Argentina Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 40: Argentina GDP and Population, 2023-2030 ($)
Figure 41: Argentina GDP – Composition of 2023, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2023-2030 ($)
Figure 43: Ecuador Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 44: Ecuador GDP and Population, 2023-2030 ($)
Figure 45: Ecuador GDP – Composition of 2023, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2023-2030 ($)
Figure 47: Peru Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 48: Peru GDP and Population, 2023-2030 ($)
Figure 49: Peru GDP – Composition of 2023, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2023-2030 ($)
Figure 51: Colombia Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 52: Colombia GDP and Population, 2023-2030 ($)
Figure 53: Colombia GDP – Composition of 2023, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2023-2030 ($)
Figure 55: Costa Rica Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 56: Costa Rica GDP and Population, 2023-2030 ($)
Figure 57: Costa Rica GDP – Composition of 2023, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2023-2030 ($)
Figure 59: Europe Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 60: U.K Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 61: U.K GDP and Population, 2023-2030 ($)
Figure 62: U.K GDP – Composition of 2023, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2023-2030 ($)
Figure 64: Germany Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 65: Germany GDP and Population, 2023-2030 ($)
Figure 66: Germany GDP – Composition of 2023, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2023-2030 ($)
Figure 68: Italy Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 69: Italy GDP and Population, 2023-2030 ($)
Figure 70: Italy GDP – Composition of 2023, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2023-2030 ($)
Figure 72: France Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 73: France GDP and Population, 2023-2030 ($)
Figure 74: France GDP – Composition of 2023, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2023-2030 ($)
Figure 76: Netherlands Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 77: Netherlands GDP and Population, 2023-2030 ($)
Figure 78: Netherlands GDP – Composition of 2023, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2023-2030 ($)
Figure 80: Belgium Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 81: Belgium GDP and Population, 2023-2030 ($)
Figure 82: Belgium GDP – Composition of 2023, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2023-2030 ($)
Figure 84: Spain Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 85: Spain GDP and Population, 2023-2030 ($)
Figure 86: Spain GDP – Composition of 2023, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2023-2030 ($)
Figure 88: Denmark Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 89: Denmark GDP and Population, 2023-2030 ($)
Figure 90: Denmark GDP – Composition of 2023, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2023-2030 ($)
Figure 92: APAC Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 93: China Digital Breast Tomosynthesis Market Value & Volume, 2023-2030
Figure 94: China GDP and Population, 2023-2030 ($)
Figure 95: China GDP – Composition of 2023, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2023-2030 ($)Digital Breast Tomosynthesis Market China Export and Import Value & Volume, 2023-2030 ($)
Figure 97: Australia Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 98: Australia GDP and Population, 2023-2030 ($)
Figure 99: Australia GDP – Composition of 2023, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2023-2030 ($)
Figure 101: South Korea Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 102: South Korea GDP and Population, 2023-2030 ($)
Figure 103: South Korea GDP – Composition of 2023, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2023-2030 ($)
Figure 105: India Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 106: India GDP and Population, 2023-2030 ($)
Figure 107: India GDP – Composition of 2023, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2023-2030 ($)
Figure 109: Taiwan Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 110: Taiwan GDP and Population, 2023-2030 ($)
Figure 111: Taiwan GDP – Composition of 2023, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2023-2030 ($)
Figure 113: Malaysia Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 114: Malaysia GDP and Population, 2023-2030 ($)
Figure 115: Malaysia GDP – Composition of 2023, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2023-2030 ($)
Figure 117: Hong Kong Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 118: Hong Kong GDP and Population, 2023-2030 ($)
Figure 119: Hong Kong GDP – Composition of 2023, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2023-2030 ($)
Figure 121: Middle East & Africa Digital Breast Tomosynthesis Market Middle East & Africa 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 122: Russia Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 123: Russia GDP and Population, 2023-2030 ($)
Figure 124: Russia GDP – Composition of 2023, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2023-2030 ($)
Figure 126: Israel Digital Breast Tomosynthesis Market Value & Volume, 2023-2030 ($)
Figure 127: Israel GDP and Population, 2023-2030 ($)
Figure 128: Israel GDP – Composition of 2023, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2023-2030 ($)
Figure 130: Entropy Share, By Strategies, 2023-2030* (%)Digital Breast Tomosynthesis Market
Figure 131: Developments, 2023-2030*Digital Breast Tomosynthesis Market
Figure 132: Company 1 Digital Breast Tomosynthesis Market Net Revenue, By Years, 2023-2030* ($)
Figure 133: Company 1 Digital Breast Tomosynthesis Market Net Revenue Share, By Business segments, 2023 (%)
Figure 134: Company 1 Digital Breast Tomosynthesis Market Net Sales Share, By Geography, 2023 (%)
Figure 135: Company 2 Digital Breast Tomosynthesis Market Net Revenue, By Years, 2023-2030* ($)
Figure 136: Company 2 Digital Breast Tomosynthesis Market Net Revenue Share, By Business segments, 2023 (%)
Figure 137: Company 2 Digital Breast Tomosynthesis Market Net Sales Share, By Geography, 2023 (%)
Figure 138: Company 3Digital Breast Tomosynthesis Market Net Revenue, By Years, 2023-2030* ($)
Figure 139: Company 3Digital Breast Tomosynthesis Market Net Revenue Share, By Business segments, 2023 (%)
Figure 140: Company 3Digital Breast Tomosynthesis Market Net Sales Share, By Geography, 2023 (%)
Figure 141: Company 4 Digital Breast Tomosynthesis Market Net Revenue, By Years, 2023-2030* ($)
Figure 142: Company 4 Digital Breast Tomosynthesis Market Net Revenue Share, By Business segments, 2023 (%)
Figure 143: Company 4 Digital Breast Tomosynthesis Market Net Sales Share, By Geography, 2023 (%)
Figure 144: Company 5 Digital Breast Tomosynthesis Market Net Revenue, By Years, 2023-2030* ($)
Figure 145: Company 5 Digital Breast Tomosynthesis Market Net Revenue Share, By Business segments, 2023 (%)
Figure 146: Company 5 Digital Breast Tomosynthesis Market Net Sales Share, By Geography, 2023 (%)
Figure 147: Company 6 Digital Breast Tomosynthesis Market Net Revenue, By Years, 2023-2030* ($)
Figure 148: Company 6 Digital Breast Tomosynthesis Market Net Revenue Share, By Business segments, 2023 (%)
Figure 149: Company 6 Digital Breast Tomosynthesis Market Net Sales Share, By Geography, 2023 (%)
Figure 150: Company 7 Digital Breast Tomosynthesis Market Net Revenue, By Years, 2023-2030* ($)
Figure 151: Company 7 Digital Breast Tomosynthesis Market Net Revenue Share, By Business segments, 2023 (%)
Figure 152: Company 7 Digital Breast Tomosynthesis Market Net Sales Share, By Geography, 2023 (%)
Figure 153: Company 8 Digital Breast Tomosynthesis Market Net Revenue, By Years, 2023-2030* ($)
Figure 154: Company 8 Digital Breast Tomosynthesis Market Net Revenue Share, By Business segments, 2023 (%)
Figure 155: Company 8 Digital Breast Tomosynthesis Market Net Sales Share, By Geography, 2023 (%)
Figure 156: Company 9 Digital Breast Tomosynthesis Market Net Revenue, By Years, 2023-2030* ($)
Figure 157: Company 9 Digital Breast Tomosynthesis Market Net Revenue Share, By Business segments, 2023 (%)
Figure 158: Company 9 Digital Breast Tomosynthesis Market Net Sales Share, By Geography, 2023 (%)
Figure 159: Company 10 Digital Breast Tomosynthesis Market Net Revenue, By Years, 2023-2030* ($)
Figure 160: Company 10 Digital Breast Tomosynthesis Market Net Revenue Share, By Business segments, 2023 (%)
Figure 161: Company 10 Digital Breast Tomosynthesis Market Net Sales Share, By Geography, 2023 (%)
Figure 162: Company 11 Digital Breast Tomosynthesis Market Net Revenue, By Years, 2023-2030* ($)
Figure 163: Company 11 Digital Breast Tomosynthesis Market Net Revenue Share, By Business segments, 2023 (%)
Figure 164: Company 11 Digital Breast Tomosynthesis Market Net Sales Share, By Geography, 2023 (%)
Figure 165: Company 12 Digital Breast Tomosynthesis Market Net Revenue, By Years, 2023-2030* ($)
Figure 166: Company 12 Digital Breast Tomosynthesis Market Net Revenue Share, By Business segments, 2023 (%)
Figure 167: Company 12 Digital Breast Tomosynthesis Market Net Sales Share, By Geography, 2023 (%)
Figure 168: Company 13Digital Breast Tomosynthesis Market Net Revenue, By Years, 2023-2030* ($)
Figure 169: Company 13Digital Breast Tomosynthesis Market Net Revenue Share, By Business segments, 2023 (%)
Figure 170: Company 13Digital Breast Tomosynthesis Market Net Sales Share, By Geography, 2023 (%)
Figure 171: Company 14 Digital Breast Tomosynthesis Market Net Revenue, By Years, 2023-2030* ($)
Figure 172: Company 14 Digital Breast Tomosynthesis Market Net Revenue Share, By Business segments, 2023 (%)
Figure 173: Company 14 Digital Breast Tomosynthesis Market Net Sales Share, By Geography, 2023 (%)
Figure 174: Company 15 Digital Breast Tomosynthesis Market Net Revenue, By Years, 2023-2030* ($)
Figure 175: Company 15 Digital Breast Tomosynthesis Market Net Revenue Share, By Business segments, 2023 (%)
Figure 176: Company 15 Digital Breast Tomosynthesis Market Net Sales Share, By Geography, 2023 (%)